Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
UBS
Medtronic
Citi
Chinese Patent Office
Boehringer Ingelheim
Federal Trade Commission
Julphar

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019816

« Back to Dashboard

NDA 019816 describes ORUVAIL, which is a drug marketed by Wyeth Pharms Inc and is included in one NDA. Additional details are available on the ORUVAIL profile page.

The generic ingredient in ORUVAIL is ketoprofen. There are twenty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Summary for 019816
Tradename:ORUVAIL
Applicant:Wyeth Pharms Inc
Ingredient:ketoprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019816

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Sep 24, 1993TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength150MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 8, 1995TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Feb 8, 1995TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Citi
Baxter
UBS
Farmers Insurance
Johnson and Johnson
Express Scripts
Merck
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.